New evidence on α-synuclein and Tau binding to conformation and sequence specific GC* rich DNA: Relevance to neurological disorders

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue 2, 2012, Pages 112-117

  Vasudevaraju, P ^a   Guerrero, Erika ^b   Hegde, Muralidhar L ^c   Collen, T B ^d   Britton, Gabrielle B ^b   Rao, K S ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b INSTITUTO DE INVESTIGACIONES CIENTÍFICAS Y SERVICIOS DE ALTA TECNOLOGÍA   (Panama)

^c University of Texas Medical Branch School of Medicine   (United States)

^d Department of Clinical Biochemistry   (Panama)

Author keywords

Synuclein; Alzheimer's disease; oligonucleotide protein interaction; Parkinson's disease; Tau; Z DNA

Indexed keywords

ALPHA SYNUCLEIN; CYTOSINE; DNA; ETHIDIUM BROMIDE; GENOMIC DNA; GUANOSINE; OLIGONUCLEOTIDE; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA CONFORMATION; DNA SEQUENCE; GENE EXPRESSION; HUMAN; NERVE DEGENERATION; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STABILITY;

EID: 84859786453     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.94811     Document Type: Article

References (38)

1. Rich A. DNA comes in many forms. Gene 1993;135:99-109.
2. Bacolla A, Wells RD. Non-B DNA conformations as determinants of mutagenesis and human disease. Mol Carcinog 2009;48:273-85.
3. Hegde ML, Vasudevaraju P, Rao KJ. DNA induced folding/fibrillation of alpha-synuclein: New insights in Parkinson's disease. Front Biosci 2010;15:418-36.
4. Vasudevaraju P, Bharathi, Garruto RM, Sambamurti K, Rao KS. Role of DNA dynamics in Alzheimer's disease. Brain Res Rev 2008;58:136-48.
5. Hegde ML, Gupta VB, Anitha M, Harikrishna T, Shankar SK, Muthane U, et al. Studies on genomic DNA topology and stability in brain regions of Parkinson's disease. Arch Biochem Biophys 2006;449:143-56.
6. Suram A, Rao KS, Latha KS, Viswamitra MA. First evidence to show the topological change of DNA from B-DNA to Z-DNA conformation in the hippocampus of Alzheimer's brain. Neuromolecular Med 2002;2:289-97.
7. Hegde ML, Anitha S, Latha KS, Mustak MS, Stein R, Ravid R, et al. First evidence for helical transitions in supercoiled DNA by amyloid Beta Peptide (1-42) and aluminum: A new insight in understanding Alzheimer's disease. J Mol Neurosci 2004;22:19-31.
8. Loomis PA, Howard TH, Castleberry RP, Binder LI. Identification of nuclear tau isoforms in human neuroblastoma cells. Proc Natl Acad Sci USA 1990;87:8422-6.
9. Maroteaux L, Campanelli JT, Scheller RH. Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 1998;8:2804-15.
10. Hegde ML, Rao KS. DNA induces folding in alpha-synuclein: Understanding the mechanism using chaperone property of osmolytes. Arch Biochem Biophys 2007;464:57-69.
11. Bisaglia M, Mammi S, Bubacco L. Structural insights on physiological functions and pathological effects of alpha-synuclein. FASEB J 2009;23:329-40.
12. Broersen K, van den Brink D, Fraser G, Goedert M, Davletov B. Alphasynuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation. Biochemistry 2006;45:15610-6.
13. Surguchov A. Molecular and cellular biology of synucleins. Int Rev Cell Mol Biol 2008;270:225-317.
14. Waxman EA, Giasson BI. Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim Biophys Acta 2009;1792:616-24.
15. Goers J, Manning-Bog AB, McCormack AL, Millett IS, Doniach S, Di Monte DA, et al. Nuclear localization of alpha-synuclein and its interaction with histones. Biochemistry 2003;42:8465-71.
16. Lin WL, DeLucia MW, Dickson DW. Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy. Neurosci Lett 2004;354:99-102.
17. Zhang L, Zhang C, Zhu Y, Cai Q, Chan P, Uéda K, et al. Semiquantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: An immunogold electron microscopic study using a C-terminal specific monoclonal antibody. Brain Res 2008;1244:40-52.
18. Brunden KR, Trojanowski JQ, Lee VM. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov 2009;8:783-93.
19. Spires-Jones TL, Stoothoff WH, de Calignon A, Jones PB, Hyman BT. Tau pathophysiology in neurodegeneration: A tangled issue. Trends Neurosci 2009;32:150-9.
20. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 1975;72:1858-62.
21. Davis PK, Johnson GV. The microtubule binding of Tau and high molecular weight Tau in apoptotic PC12 cells is impaired because of altered phosphorylation. J Biol Chem 1999;274:35686-92.
22. Haque N, Tanaka T, Iqbal K, Grundke-Iqbal I. Regulation of expression, phosphorylation and biological activity of tau during differentiation in SY5Y cells. Brain Res 1999;838:69-77.
23. Wang Y, Thomas GA, Peticolas WL. Sequence dependent conformations of oligomeric DNA's in aqueous solutions and in crystals. J Biomol Struct Dyn 1987;5:249-74.
24. Antequera F. Structure, function and evolution of CpG island promoters. Cell Mol Life Sci 2003;60:1647-58.
25. Trewick SA, Dearden P. A rapid protocol for DNA extraction and primer annealing for PCR sequencing. Biotechniques 1994;17:842-4.
26. Gray DM, Hung SH, Johnson KH. Absorption and circular dichroism spectroscopy of nucleic acid duplexes and triplexes. Methods Enzymol 1995;246:19-34.
27. Chatterjee B, Rao GRK. Superhelical density of goat mitochondrial DNA: Fluorescent studies. Indian J Biochem Biophys 1994;31:77-9.
28. Scatchard G. The attraction of proteins for small molecules and ions. Ann N Y Acad Sci (USA) 1949;51:660-72.
29. Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 1953;171:737-8.
30. Ghosh A, Bansal MA. Glossary of DNA structures from A to Z. Acta Crystallogr D Biol Crystallogr 2003;59:620-6.
31. Hinoi E, Balcar VJ, Kuramoto N, Nakamichi N, Yoneda Y. Nuclear transcription factors in the hippocampus. Prog Neurobiol 2002;68:145-65.
32. Liu H, Mulholland N, Fu H, Zhao K. Cooperative activity of BRG1 and Z-DNA formation in chromatin remodeling. Mol Cell Biol 2006;26:2550-9.
33. Oh DB, Kim YG, Rich A. Z-DNA-binding proteins can act as potent effectors of gene expression in vivo. Proc Natl Acad Sci USA 2002;99:16666-71.
34. Wang AH, Quigley GJ, Kolpak FJ, Crawford JL, van Boom JH, van der Marel G, et al. Molecular structure of a left-handed double helical DNA fragment at atomic resolution. Nature 1979;282:680-6.
35. Rich A, Zhang S. Timeline: Z-DNA: The long road to biological function. Nat Rev Genet 2003;4:566-72.
36. Li H, Xiao J, Li J, Lu L, Feng S, Dröge P. Human genomic Z-DNA segments probed by the Z alpha domain of ADAR1. Nucleic Acids Res 2009;37:2737-46.
37. Dröge P, Pohl FM. The influence of an alternate template conformation on elongating phage T7 RNA polymerase. Nucleic Acids Res 1991;19:5301-6.
38. Oh WJ, Noggle SA, Maddox DM, Condie BG. The mouse vesicular inhibitory amino acid transporter gene: Expression during embryogenesis, analysis of its core promoter in neural stem cells and a reconsideration of its alternate splicing. Gene 2005;351:39-49.